Clinical Trial Update: Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC) [Phase 2]

View source ↗

Summary

This Phase II trial compared the ECX regimen (epirubicin, cisplatin, capecitabine) with cisplatin plus capecitabine (CX) for advanced gastric cancer. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• Epirubicin (epirubicin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Advanced Gastric Cancer | Phase 2 | Status: COMPLETED